Rapid Detection Techniques for Cryptosporidium and Giardia: Feasibility of Use to Assess Risk From Drinking Wilderness Waters
Introduction.-A quantitative polymerase chain reaction (QPCR) protocol for detection of Cryptosporidium and Giardia was developed and applied to natural waters collected from Yosemite National Park. The protocol involved concentrating (oo)cysts seeded into a target water onto nitrocellulose filters, extracting DNA from the filters, and subsequently amplifying (oo)cyst-specific genes for organism quantification.
Methods.-Numerous methods for improving DNA extraction efficiency were evaluated, including washing filters to remove organisms and then concentrating wash water before DNA extraction, directly extracting DNA from filters with commercial extraction kits, and adding carrier RNA and Geotrichium candidum cells to samples. Methods for coping with inhibition were also assessed, including addition of BSA and Chelex, utilization of extraction kits designed to remove PCR inhibitors, and dilution of extraction eluates before QPCR amplification.
Results.-Using MILLIQ (ultrapure water) as the target water, we could detect concentrations as low as 100 Giardia cysts per liter, but we could not detect Cryptosporidium oocysts even at concentrations of 1000 oocysts per liter. When the target water was a natural surface water, the assay sensitivity decreased, as our detection limit rose to Ն1000 Giardia cysts. We did not detect Giardia and Cryptosporidium organisms in any of the 34 samples collected from Yosemite. Because the inoculum required to establish infection in humans is only 10 to 100 organisms, the detection limit of our protocol is too high to calculate the risk of infection associated with drinking wilderness surface waters.
Conclusion.-We conclude that, at present, QPCR is not sensitive enough to detect (oo)cysts in environmental waters with the goal of protecting human health. Although QPCR is a promising approach for quantification of pathogens in natural waters, more work is needed to improve sensitivity. Future research should focus on improving methods of (oo)cyst collection, DNA extraction and purification, and QPCR amplification to allow detection of low levels of pathogens in environmental waters. Introduction.-The foraging of wild mushrooms can be complicated by toxicity from several mushroom types. Ama-toxin, a peptide contained in several mushroom species, accounts for the majority of severe mushroom poisonings by irreversibly binding to RNA polymerase II, leading to severe hepatonecrosis. Currently, there is no antidote for severe amatoxin poisoning.
Objective.-The objective of this study was to compare the effectiveness of 5 potential antidotal therapies in limiting the degree of hepatonecrosis in a randomized, controlled murine model of amatoxin-induced hepatotoxicity.
Method.-One hundred eighty male ICR mice were randomized into 6 equal groups. Within each group, 21 mice were intraperitoneally (IP) injected with 0.6 mg·kg Ϫ1 of alpha amanitin (amatoxin); the remaining 9 were injected with 0.9% normal saline. Four hours postinjection, each group of 30 mice was randomized to 1 of 5 IP treatments (N-acetylcysteine, benzylpenicillin, cimetidine, thioctic acid, or silybin) or normal saline. Repeat dosing was administered IP every 4 to 6 hours for 48 hours. After 48 hours of treatment, each subject was euthanized, cardiac blood was aspirated for hepatic transaminase measurements (alanine aminotransferase and aspartate aminotransferase), and liver specimens were harvested to evaluate the extent of hepatonecrosis. The degree of hepatonecrosis was determined by a pathologist blinded to the treatment group, and the specimens were divided into 5 categories based on percentage of hepatonecrosis.
Results. Introduction.-Massive bee envenomation in adults is associated with a greater than 15% mortality. Melittin, phospholipase A 2 , and hyaluronidase in bee venom produces vomiting, diarrhea, shock, hemoglobinuria, rhabdomyolysis, multiorgan failure, and death. Experience with adults and animals suggests that clinical manifestations largely depend on the number of stings per kilogram of body weight. Animal data suggest death is inevitable when more than 20 stings per kilogram are present. Data on children are extremely limited. We describe our experience with multiple bee stings in 11 children (Ͻ10 years old).
Methods.-The 11 children had a median age of 3.6 years (range 2-9 years). All bee stingers were counted. The admitting medical toxicologist recorded all signs and symptoms. Electrolytes, creatine kinase, complete blood cell count, prothrombin time and partial thromboplastin time, fibrinogen, and renal function were measured serially in all patients. Laboratory data were measured at baseline, 8, and 16 hours after presentation. A standard form was retrospectively completed. Telephone follow-up at 4 days postenvenomation was performed.
Results.-The median total stingers was 48 per patient (range 25-50) or 2.64 stingers per kilogram (range 1-4.5). No child had any signs of anaphylaxis. Nine of 11 children had vomiting that resolved within 90 minutes of envenomation, with 8 patients receiving 1 dose of an antiemetic (droperidol, hydroxyzine, etc). Seven of 11 children had at least 1 episode of nonbloody diarrhea within 2 hours of envenomation. Mild elevations in creatine kinase were present in all children (median 181 IU·L
Ϫ1
; range 141-191 IU·L
), whereas all other laboratory data remained normal. All patients were discharged the next day with complete resolution of the symptoms and normal laboratory data. Telephone follow-up at 4 days postenvenomation was unremarkable.
Conclusions.-Bee envenomation resulted in mild systemic illness and mild elevation of creatine kinase in our series of children receiving 1 to 4.5 stings per kilogram. Among these systemic symptoms were nausea, vomiting, and diarrhea. Given previous animal research, adult case studies, and our study in children, 2 conclusions can reasonably be drawn. First, systemic illness does result from Africanized bee attacks, the severity of which depends on the number of stings per kilogram. Second, the presence of systemic symptoms does not necessarily portend a poor prognosis. Introduction.-Oxygen is used as a therapeutic agent to treat a variety of medical conditions in both clinical and field settings. Closed-circuit oxygen rebreathers can maximize delivery fraction with minimal flow requirements. The Divers Alert Network developed a compact, unidirectional-flow, closed-circuit oxygen rebreather suitable for remote field use (REMO 2 ). A second-generation device was produced after key components of the first could no longer be procured. The second-generation device consisted of a solid, prepacked CO 2 scrubber canister integrated with standard 22-mm inside-diameter anesthesia circuit hoses and fittings, a 5-L breathing bag, a 5-cmH 2 O positive-expiratory end-pressure valve, and an oronasal mask. Our purpose was to evaluate second-generation device performance for comparison with the first-generation system.
Methods.-Six trials were completed under standard laboratory conditions with healthy volunteers of varying size (73-126 kg). Subjects breathed on the circuit until the CO 2 concentration at the scrubber outlet reached 3.8 mm Hg ('breakthrough') or for a maximum duration of 8 hours. Measured parameters included inspired oxygen fraction (F I O 2 ), oxygen flow, scrubber duration, and breathing resistance. We completed similar testing with the first-generation device previously (n ϭ 6; 59-123 kg). All data reported as mean Ϯ SD.
Results.-Mean F I O 2 (0.95 Ϯ 0.04 and 0.95 Ϯ 0.06) and mean oxygen flow (1.06 Ϯ 1.36 and 1.05 Ϯ 0.16 L·min Ϫ1 ) were similar for second-and first-generation devices, respectively. The scrubber duration was markedly improved with the second-generation system. The only trial ending in breakthrough did so at 7.8 hours. Breakthrough with the first-generation was reached in 5.7 Ϯ 1.8 hours. Breathing resistance was also less extreme with the second-generation system (Ϫ5.2 Ϯ 1.9 cmH 2 O inspiratory; 6.5 Ϯ 1.9 cmH 2 O expiratory) than with the first-generation system (Ϫ6.7 Ϯ 1.6 cm H 2 O inspiratory; 9.2 Ϯ 1.5 cmH 2 O expiratory).
Conclusion.-Testing confirmed that the second-generation REMO 2 circuit performed in a manner similar or superior to the first-generation device for all parameters tested. Introduction.-Adventure races or wilderness multisport endurance events continue to grow in popularity with increasing numbers of events and participants each year. The provision of medical support for these events is both challenging and exciting. Athletes are treated for a wide variety of both injury and illness during these events, including altered mental status. The differential diagnosis for altered mental status includes heat stroke, dehydration, altitude illness, infection, toxic ingestion, head injury, hyponatremia, mental illness, and sleep deprivation. Depending on the situation, it may be difficult to determine the exact etiology.
Objective.-Previously, athletes have reported hallucinations to medical personnel during adventure races; however, the incidence is unknown. The objective of this study is to determine the incidence of hallucinations in these athletes. This information will assist medical providers in their evaluation of athletes presenting with altered mental status.
Methods.-The 2004 Subaru Primal Quest Expedition Length Adventure Race was held in the Northern Cascade Mountains of Washington State. During prerace registration, athletes were asked to complete a questionnaire about hallucinations during previous adventure races. The results were used to determine the incidence of hallucinations during adventure races.
Results.-Of the 250 athletes eligible to participate in the study, 240 agreed to participate and were enrolled. Of those athletes completing the questionnaire, more than 75% reported hallucinations during previous adventure races. The majority of these hallucinations were visual. Conclusion.-Athletes participating in expedition-length adventure races are treated for a wide variety of injury and illness. When an athlete presents with altered mental status, it is often difficult to determine the etiology of his or her symptoms. This study demonstrates the high incidence of hallucinations during these events, highlighting a potential and previously underrecognized cause of altered mental status in these athletes. Objective.-The aim was to determine the incidence and nature of morbidity on short adventurous expeditions.
Methods.-A single observer conducted a retrospective analysis of the medical records. A total of 1452 individuals participated in 42 expeditions during 2003. Twenty-one expeditions reported no incidents requiring medical intervention. The remaining 21 expeditions reported a total of 84 incidents (5% overall incidence of a medical incident). Of these, 7 required evacuation to a local medical facility and 3 more were repatriated to the UK. There were no fatalities.
Results.-Gastrointestinal illness was the most common disorder on expedition, causing 26% of all medical incidents (22 individuals) and affecting 28% of all expeditions. Five individuals required antiemetics, and only 1 required intravenous fluids. None were evacuated. Musculoskeletal injuries represented 15% of all reported incidents. All but 1 was a lower limb injury. Other conditions included acute mountain sickness (12% of incidents), dermatological conditions (10.7%), respiratory conditions (8%), and heat or cold conditions (8%). There was only 1 surgical condition (appendicitis). There were no tropical diseases, psychiatric conditions, or road traffic collisions. The commonest cause of evacuation was respiratory illness (30% of evacuations).
Conclusions.-For this cohort, accidents were not a cause of morbidity on expedition. This may be a manifestation of an increasing ratio of staff to participants, coupled with an early expedition briefing. The high proportion of gastrointestinal dis-eases could perhaps be partially prevented with stricter public health regimens and participant education. Altitude sickness may be minimized if guidelines regarding ascent to altitude and acclimatization are followed. It is surprising that respiratory diseases were the commonest cause of evacuation. Objective.-The objective of this study was to measure the decrease in core body temperature after extrication from snow burial (afterdrop) and measure core body temperature during passive rewarming in the field.
Methods.-Esophageal core body temperature (T e ) was measured in 6 subjects buried in compacted snow (mean density 39%) for up to 60 minutes at an altitude of 8000 feet (P b 571 mm Hg). Subjects breathed with an AvaLung (Black Diamond Equipment, Salt Lake City, UT) device during snow burial. Mean snow temperature was Ϫ3.5 Ϯ 1.0ЊC and mean ambient air temperature was 0 Ϯ 2ЊC. Subjects were dressed in a lightweight clothing insulation system consisting of a 1-piece Gore-Tex suit over medium-weight Capilene underwear with a hood, face mask, goggles, mittens, and warm boots. After extrication from snow burial, subjects breathed ambient air as they were hastily placed in a sleeping bag wrapped in a blanket on an insulating pad. Heavy plastic was wrapped around all insulating layers to complete the hypothermia wrap. Core body temperature was measured for an additional 60 minutes as subjects were allowed to passively rewarm by shivering.
Results.-T e cooling rate during snow burial was 0.8 Ϯ 0.3 ЊC·h Ϫ1 during a mean burial time of 58 Ϯ 4 minutes. T e afterdrop occurred over 12 Ϯ 8 minutes after extrication from snow burial with a T e cooling rate of 4.0 Ϯ 0.8ЊC·h Ϫ1 (P Ͻ .001 T e cooling rate during snow burial vs afterdrop). Rewarming occurred after the nadir of the T e at a rate of 1.1 Ϯ 0.3ЊC·h Ϫ1 over the subsequent 48 Ϯ 8 minutes during passive rewarming (P ϭ .05 snow burial cooling vs passive rewarming rate of T e ).
Conclusion.-Core body temperature cooling rate after extrication from snow burial increased about 4-fold for a transient period in subjects who were placed as quickly as possible into an insulating hypothermia wrap. Passive rewarming increased core body temperature at about the same rate that it decreased during snow burial. These findings suggest that field rewarming of avalanche burial victims with mild hypothermia who are shivering is possible, but they should be insulated quickly to limit the significant afterdrop that may occur. Introduction.-Hypothermia is a frequent complication of cold weather exposure and wilderness injuries. Anecdotal reports have postulated that patients with acute hypothermia are at significantly increased risk of developing lethal cardiac dysrhythmias secondary to the physical stimulation from moving and transporting patients.
Objective.-To determine the ability of rough handling and sudden movement to induce lethal cardiac dysrhythmias in a controlled animal study of mild to severe hypothermia.
Methods.-Ten anesthetized swine had continuous cardiac and invasive blood pressure monitoring. Core body temperature (CBT) was measured with an esophageal probe. Animals were secured to a backboard in a supine position for the duration of the study and their CBT was serially lowered by external cooling measures. At preset intervals (every 3ЊC lowered from the baseline CBT of 38ЊC) the animals were lifted via the backboard and rolled 90 degrees to the left and held for 5 seconds, brought back to horizontal, and then rolled to the right and held for 5 seconds. After rolling, the swine were lifted via the backboard 6 inches off the operating room table and dropped back onto the table; 15 seconds later this was repeated at 12 inches. If no signs of arrhythmia were noted, external cooling was continued.
Results.-Two (20%) swine developed fatal arrhythmias (Vfib) during mechanical stimulation but not until CBT was 20ЊC. Five (50%) of the animals developed V-fib (3 V-fib, 2 asystole) with no stimulation but at CBT Յ 25ЊC (average CBT 22.7ЊC). No animal developed a dysrhythmia at a CBT Ͼ 25ЊC with or without stimulation.
Conclusion.-Severe hypothermia induces fatal dysrhythmias. Mechanical stimulation in animals with severe hypothermia may contribute to the induction of fatal arrhythmias.
